Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images
Launched by WUERZBURG UNIVERSITY HOSPITAL · Aug 8, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how to better train doctors to recognize certain types of growths in the colon, known as polyps, which can sometimes lead to cancer. Traditionally, doctors have learned by looking at images of these growths and practicing on patients. In this study, researchers want to see if using images created by artificial intelligence (AI) can improve this training. These AI-generated images can be designed to show different stages of precancerous polyps while still respecting patient privacy.
Doctors who are interested in this trial can participate whether they are experienced in performing colonoscopies or are new to the procedure. The study will compare how well physicians can identify polyps using both real images and AI-generated images. Participants can expect to help advance the training methods for doctors, which may lead to earlier detection of colon cancer in the future. The trial is not yet recruiting participants, but it aims to include a wide range of physicians in its research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physicians with or without experience in colonoscopy
About Wuerzburg University Hospital
Würzburg University Hospital, a leading academic medical center in Germany, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution within the University of Würzburg, it combines cutting-edge scientific inquiry with comprehensive patient care. The hospital is committed to improving medical outcomes by fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities. With a focus on translating research findings into practical applications, Würzburg University Hospital plays a pivotal role in driving medical advancements and enhancing patient quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alexander Hann
Principal Investigator
Wuerzburg University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported